Wield Therapeutics is focused on developing genetics-driven solutions for autoimmune diseases. Led by an experienced team with a history of success in drug development, including innovative approvals and significant exits, Wield is committed to a fast, high probability of technical success (PTS) approach. Wield leverages genetic validation and predictive biomarkers to increase clinical success and shorten trial timelines.
Company Details
- Founded
- 2025
- Address
- San Mateo, Ca, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Immunology and Autoimmune disease.
- HQ
- San Mateo, CA
Wield Therapeutics, Inc. Questions
Wield Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/wieldtx
Wield Therapeutics, Inc.'s industry is
Biotechnology Research
Wield Therapeutics, Inc.'s top competitors are
Xaira Therapeutics,
Genomictree Inc,
23andme,
Abtherx,
Pheast Therapeutics,
92bio, Inc.,
Seegene Usa,
Fortvita Biologics,
Elaria,
Amgen.
Wield Therapeutics, Inc.'s categories are Biotechnology Research
Wield Therapeutics, Inc.'s founding year is 2025
